<DOC>
	<DOCNO>NCT01016470</DOCNO>
	<brief_summary>The purpose study evaluate whether Viusid/Alzer Nutritional supplement , could improve progression disease , patient Parkinson 's Disease ( PD ) .</brief_summary>
	<brief_title>Efficacy Nutritional Supplement VIUSID/ALZER Patients With Parkinson ` Disease</brief_title>
	<detailed_description>Periodical measure clinical feature UPDRS do beginning , three month two year . Each group compare evaluate .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patients clinical PD , criterion Brain Bank London early stage . Informed consent . Presence another disease well control . Patient atypical feature . Patient advance Parkinson ` disease .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>